Knee Osteoarthritis Clinical Trial
— YEMOOfficial title:
Yoga Versus Aerobic and Strengthening Exercises for Managing Knee Osteoarthritis
NCT number | NCT02525341 |
Other study ID # | 1212M25141 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2013 |
Est. completion date | July 2016 |
Verified date | May 2019 |
Source | University of Minnesota - Clinical and Translational Science Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the study is to examine the short and long term effects of Hatha yoga compared to the current recommended exercise program in promoting physical function, alleviating osteoarthritis (OA)-related symptoms, fear of falling, and improving mood, spiritual health, physical activity level, and quality of life in older adults with knee OA, and to determine the effect sizes for use in power calculations to design a larger efficacy clinical trial.
Status | Completed |
Enrollment | 83 |
Est. completion date | July 2016 |
Est. primary completion date | July 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 60 Years to 100 Years |
Eligibility |
Inclusion Criteria: - have been diagnosed with symptomatic OA of knee for at least 6 months, - have not practiced any form of yoga for at least 2 months; and - not currently participating in a supervised exercise program. "Currently" is defined as not participating in a supervised exercise program more than 2 times a week at the time of second-step screening. Exclusion Criteria: - OA is asymptomatic, - have moderate/severe cognitive impairment, scored less than 8 on the Short Portable Mental Status Questionnaire, - have cardiovascular risk, - reported symptoms of joint locking, - instability indicated by chronic use of a knee brace, cane, walker, or wheelchair, - corticosteroid injection in the symptomatic joint within 3 months of study entry, - hyaluronic acid injection: hyaluronan (Hyalgan) and synthetic hylan G-F 20 (Synvisc) in the symptomatic joint within 6 months of study entry, - history of knee surgery within the last two years, arthroscopic lavage within 6 months, or a joint replacement of the lower extremities at any point, - self-reported significant medical comorbidities such as: 1) uncontrolled high blood pressure or existing heart condition; and 2) other comorbid condition with overlapping symptoms (i.e. fibromyalgia, rheumatoid arthritis), - Individuals who have medication changes for arthritis symptoms will be permitted to remain in the trial; however, these changes will be monitored. |
Country | Name | City | State |
---|---|---|---|
United States | University of Minnesota | Minneapolis | Minnesota |
Lead Sponsor | Collaborator |
---|---|
University of Minnesota - Clinical and Translational Science Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Feasibility - number of eligible subjects | Number of eligible subjects will be assessed by the total number of subjects enrolled in the study. | Baseline | |
Other | Feasibility - exercise adherence | Exercise adherence will be assessed base on the: Average class attendance (weekly class attendance sheet recorded by the RA) Frequency of home practice: the average number of days per week, and the average number of minutes per day (participants' weekly self-report on an exercise log sheet). |
8 weeks | |
Other | Feasibility - adverse events | RA will record any number or type of yoga related adverse events during the intervention classes. Participants will record any number or type of yoga related adverse events during their home practice on the exercise log sheet. | 8 weeks | |
Other | Feasibility - retention rate | Retention rate will be assessed by the number of participants remain in the study. | 8 weeks | |
Other | Acceptability | An investigator-developed survey using a 10 point Likert scale will be used to assess participants' self-report satisfaction with the intervention program, perceived appropriateness of the program, and intention to continue to use the intervention program. | 8 weeks | |
Primary | Osteoarthritis (OA) symptoms change | OA pain, stiffness and function (total score) is evaluated using the Western Ontario and McMaster Universities OA (WOMAC) index scale. | Change from baseline OA symtptoms at 8 weeks | |
Primary | Knee OA pain change | Visual Analog Scale | Change from baseline pain score at 8 weeks | |
Primary | Knee OA pain change | Number of pain medication used per day for OA pain | Change from baseline number of medication used per day for OA pain at 8 weeks | |
Secondary | Physical function | The Short Physical Performance Battery, which includes repeated chair stands, balance and 8 foot walk tests, is used to evaluate participants' physical function of lower extremities. | 4 and 8 weeks | |
Secondary | Gait speed | 50 foot walk is used to measure gait speed. | 4 and 8 weeks | |
Secondary | Physical activity level | Physical Activity Scale for the Elderly is used to evaluate the different physical activity levels: leisure time activity, household activity, and work-related activity. | 4 and 8 weeks | |
Secondary | Fear of falling | Fear of falling is evaluated using the Falls Efficacy Scale-International. | 4 and 8 weeks | |
Secondary | Spiritual health | Self-Transcendence Scale is used to evaluate participants' spiritual health. | 4 and 8 weeks | |
Secondary | Quality of life | SF 12 v2 Health Survey is used for measuring quality of life. | 4 and 8 weeks | |
Secondary | Mood | Hospital Anxiety and Depression Scale is used to evaluate mood. | 4 and 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04651673 -
Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
|
||
Completed |
NCT05677399 -
Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise.
|
N/A | |
Active, not recruiting |
NCT04043819 -
Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis
|
Phase 1 | |
Recruiting |
NCT06000410 -
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT05014542 -
Needling Techniques for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05892133 -
Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT05528965 -
Parallel Versus Perpendicular Technique for Genicular Radiofrequency
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Active, not recruiting |
NCT02003976 -
A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone
|
N/A | |
Active, not recruiting |
NCT04017533 -
Stability of Uncemented Medially Stabilized TKA
|
N/A | |
Completed |
NCT04779164 -
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT04006314 -
Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05423587 -
Genicular Artery Embolisation for Knee Osteoarthritis II
|
N/A | |
Enrolling by invitation |
NCT04145401 -
Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
|
||
Active, not recruiting |
NCT03781843 -
Effects of Genicular Nerve Block in Knee Osteoarthritis
|
N/A | |
Completed |
NCT05974501 -
Pre vs Post Block in Total Knee Arthroplasty (TKA)
|
Phase 4 | |
Completed |
NCT05324163 -
Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis
|
Phase 3 | |
Completed |
NCT05529914 -
Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05693493 -
Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA?
|
N/A | |
Not yet recruiting |
NCT05510648 -
Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis
|
N/A |